Perth-based biotechnology outfit BioPharmica plans to seek an initial public offer for its wholly owned subsidiary, Molecular Discovery Systems, which will focus on cancer treatments.
15/09/2009 - 11:13
BioPharmica plans IPO for subsidiary
15/09/2009 - 11:13